1. Home
  2. SCPH vs MPA Comparison

SCPH vs MPA Comparison

Compare SCPH & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • MPA
  • Stock Information
  • Founded
  • SCPH 2013
  • MPA 1992
  • Country
  • SCPH United States
  • MPA United States
  • Employees
  • SCPH N/A
  • MPA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • MPA Finance Companies
  • Sector
  • SCPH Health Care
  • MPA Finance
  • Exchange
  • SCPH Nasdaq
  • MPA Nasdaq
  • Market Cap
  • SCPH 160.6M
  • MPA 159.3M
  • IPO Year
  • SCPH 2017
  • MPA N/A
  • Fundamental
  • Price
  • SCPH $3.28
  • MPA $11.89
  • Analyst Decision
  • SCPH Strong Buy
  • MPA
  • Analyst Count
  • SCPH 2
  • MPA 0
  • Target Price
  • SCPH $15.00
  • MPA N/A
  • AVG Volume (30 Days)
  • SCPH 251.3K
  • MPA 25.2K
  • Earning Date
  • SCPH 03-12-2025
  • MPA 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • MPA 3.83%
  • EPS Growth
  • SCPH N/A
  • MPA N/A
  • EPS
  • SCPH N/A
  • MPA N/A
  • Revenue
  • SCPH $30,278,000.00
  • MPA N/A
  • Revenue This Year
  • SCPH $173.14
  • MPA N/A
  • Revenue Next Year
  • SCPH $131.01
  • MPA N/A
  • P/E Ratio
  • SCPH N/A
  • MPA N/A
  • Revenue Growth
  • SCPH 303.87
  • MPA N/A
  • 52 Week Low
  • SCPH $3.08
  • MPA $9.87
  • 52 Week High
  • SCPH $6.54
  • MPA $12.21
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 41.79
  • MPA 50.77
  • Support Level
  • SCPH $3.15
  • MPA $11.80
  • Resistance Level
  • SCPH $3.52
  • MPA $12.00
  • Average True Range (ATR)
  • SCPH 0.18
  • MPA 0.15
  • MACD
  • SCPH -0.00
  • MPA 0.01
  • Stochastic Oscillator
  • SCPH 15.22
  • MPA 44.59

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.

Share on Social Networks: